|
FY2025
12 months to Dec 31, 2025
|
FY2024
8 months to Dec 31, 2024
|
|
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net income | ||
| Adjustments to reconcile net income to net cash used in operating activities: | ||
| Change in fair value of warrant liability | ||
| Interest and dividends earned on cash and marketable securities held in Trust Account | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses and other current assets | ||
| Payable to related party | ||
| Accounts payable | ||
| Related party payable | ||
| Accrued legal services | ||
| Accrued liabilities | ||
| Other assets | ||
| Net cash used in operating activities | ||
| INVESTING ACTIVITIES | ||
| Investment of cash in Trust Account | ||
| Net cash used in investing activities | ||
| FINANCING ACTIVITIES | ||
| Proceeds from sale of public units, net of underwriting discount paid | ||
| Proceeds from the sale of private placement warrants to Founder | ||
| Proceeds from sale of Class B ordinary shares in a private placement | ||
| Payment of offering costs | ||
| Net cash provided by (used in) financing activities | ||
| Net increase (decrease) in cash | ||
| Cash at beginning of period | ||
| Cash at end of period | ||
| Supplemental non-cash disclosure: | ||
| Offering costs included in accounts payable, related party payable and accrued liabilities | ||
| Accretion of Class A ordinary shares to redemption value | ||
| Fair value of public warrants at issuance |
Loading...
